Breast cancer has been classified into different molecular subtypes, specifically, based on presence or absence of hormone receptors (HR+/HR-) for estrogen or progesterone and excessive level of human epidermal growth factor receptor 2 (HER2+/HER2-). This evidence concerns the gene ERBB2 and breast carcinoma.